Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oil flow is inevitable, too!
News flow inevitable!
"The Company remains committed to developing its business plan without the issuance of stock."
Last Share Issuance - November 12, 2015
Authorized 500,000,000
Issued & Outstanding 391,413,019
Restricted 132,349,027
Float 259,063,992
Shares Confirmed by Transfer Agent on April 6, 2017
Pacific Stock Transfer 800-785-7782
REVERSE SPLITS AND A DUMP OF ANOTHER 100 MILLION CAN HAPPEN!!! YUP, THEY HAVE 100,000,000 MORE TO DUMP IF THEY WANT.....
Great job on the shakeout! We needed some excitement here, as well as something meaningful to talk about. It's been a long, boring winter on the oilfields.
I love it :) going up !!! Shook out all haters ....
I missed the fake bond news. That must mean the bond website is full of fake info? Lloyd's of London underwriters didn't help source insurance? Those ISIN numbers aren't traceable to a real bond?
Does the infamous Norm Johnson KNOW Wright put his bio on the bond website implying he is a DIRECTOR of the bond company that is fake?
Norm Johnson:
Norm Johnson, age 56, is a business owner, entrepreneur and community philanthropist. Mr. Johnson entered the business world 16 years ago following a successful career as a place kicker in the National Football League – currently 10th on the all-time leading scorers list. Following his NFL career, Mr. Johnson began working in real estate, investing in small business and consulting with numerous entities. Mr. Johnson graduated in 1983 with a Bachelor’s degree in economics from the University of California Los Angeles (UCLA).
2001 – Present:
Real Estate Broker and Investor
Purchased and sold real estate for individual portfolios as well as represent clients in their investment choices.
2012 – Present:
Product and Brand Development
Developed product and marketing for specialty beers, spirits and energy drinks.
1982 – 1999:
National Football League
Place kicker. 10th on all-time leading scorers list. Nicknamed "Mr. Automatic."
How did he bring it down and did you guys put the DD out showing at the bond was fake
We'll have to send him a nice thank you card after the next run!
Wright brought this pos down with his scam
Agreed...one only needs to read the Amazon excerpt of his first novel, watch his sex video, consider he ran a men's club, and now claims a product he may need in his old age?
Maybe he needs a 12-step program?
http://www.imdb.com/name/nm2947997
Lot's of hands on experience no doubt.
African Viagra? Could be an Otiko "secret ingredient"!
Seriously, I would not buy on that last pumped-up news release. This warning just confirms I made the right decision. No one knows where and how he formulates and clinically tests his products.
I expect the FDA to reject his invention.
FDA Warning just out!!
https://www.benzinga.com/news/17/04/9276350/fda-warns-of-dangerous-hidden-ingredient-in-5-otc-male-sexual-enhancement-supplem
This is just what VDRM needed
Proof is on their OTC Profile page. See link below for details.
TA updates monthly or when changes occur. They updated March 1, then March 7, then March 31.
Annual Report is due next week.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130160152
You have no proof he is dumping shares.
22 million in last 3 weeks. TA updates on OTC Profile.
VDRM is biggest POS, Doc is diluting shares, period
Primarily, what we have here is a failure to adequately define their licensing business model. There is just so much digging that can be done. It's up to Otiko to fill in the blanks.
After three years of using public money to build a licensing business, it appears Otiko has only licensed Phillips Company products (for which he pays a patent license fee) to his own business, Coast to Coast Podiatry in Reseda. Today, he has one non-exclusive agreement for Viabecline, a clone of a product that won the Edison Award five years ago.
As a side issue, the Phillips/Keough delivery system is one big fat question mark. Why won't Otiko explain his relationship with Phillips and Keough? What happened that made Keough distance himself from Phillips? Did this involve Otiko? Is it true Otiko thinks that invention is up for grabs--that he can submit a patent application and expect it to be accepted?
Product development is a big question mark, too. Where are products being developed? Are legitimate clinical trials being conducted? Are the announced products actually Phillips Company products?
Otiko is a Doctor of Podiatric Medicine. DPM's are foot specialists.
In the United States, Doctors of Podiatric Medicine (DPM) are physicians and surgeons who practice on the lower extremities, primarily on feet and ankles.[3] The preparatory education of most podiatrists includes four years of undergraduate work, followed by four years in an accredited podiatric medical school, followed by a three or four-year hospital-based surgical residency. Podiatrists are licensed in all 50 states.[4]
Just one more note: The doctor is a physician instead of a foot specialist. Therefore, he deals problems in a wide area of medicine.
By 2006, Chris was a successful doctor living in Los Angeles, who owned several clinics and other ventures such as an adult entertainment club. However he ran into financial problems when he was dragged into a federal case, which he was eventually exonerated from.
During his lengthy legal battle, his finances took a major hit and he was unable to find work because of the bad publicity. That was when he started working on the idea for "Santa." He finally completed "Santa," the first of the proposed Kim Kramer series, in 2012.
This is why Otiko needs to lay it all out in the Annual Report. We deserve to understand his intentions with the Phillips/Keough delivery system on which his non-exclusive license is based.
Is Otiko basing his future products on the delivery system he has been touting for years? Are these truly unique inventions that will withstand the scrutiny of the USPTO and FDA where appropriate?
If Okito is truly operating like Keogh says, then he's either the dumbest person on planet earth or a thief. Or, both.
That "amazing product" won the Edison Award five years ago, in 2012. Dakota Life Sciences/ThruPharma/Keough holds the Trademark to Diabecline.
We believe in the core technology, and have solid plans to use it going forward. We did a voluntary recall in 2014 for the Diabecline branded antibiotic swab because the formulation was causing deterioration of the swab tip. We will not have that configuration going forward, but will be using and protecting the technology.
He is diversifying his time? He has an amazing product what else does he need to do now? Bring to market and he is doing that. In addition he is applying his tech to as many other things as he can couple it with. why? Because his life. Has new meaning and he is backed into a corner willing to do anything to get his like and passion back together sounds reasonable to me..
That's possible yet in full view with all other behaviors, I think he could be playing the victim. I think he's manipulative. I think he knew what she was doing.
Celeste is now living in Texas. Otiko remarried early 2014 just before he and his wife, Ekaterina, went public. He doesn't reveal she is his wife in disclosures but he does reveal Manny is his brother. Ekaterina and Manny are Directors.
He issued the Coast to Coast news release a year ago, saying they signed an agreement to distribute products with them, that it was mutually beneficial, and didn't reveal they owned it--that this is their podiatry clinic.
http://www.otcmarkets.com/stock/VDRM/news/ViaDerma-announces-new-deal?id=131588&b=y
Sounds like his wife screwed him over
Now, he's trying to start over with a new career outside of medicine.
Otiko is a smart and capable foot and ankle doctor. Some links to review are below.
*****
08/29/2009
PODIATRISTS AND THE LAW - PART 1
CA Podiatrist Acquitted on Trumped Up Drug Charges But Must Start New Life
An Inland, CA podiatrist is trying to rebuild his life after being acquitted in a prescription fraud case that authorities said was nationwide. More than two years ago, Christopher Otiko was accused of ordering prescriptions illegally for his wife, who was arrested earlier in the same case. "It was the worst experience of my life," he said.
http://podiatrym.com/search3.cfm?id=66969
*****
CA Podiatrist Helps Develop Topical Antibiotic
A Reseda, CA podiatrist who helped develop the topical antibiotic Diabecline has been using it on patients since April. He calls the results incredible. Dr. Ayo Otiko said it saved a diabetic woman last year from a possible foot amputation. Otiko said the woman, 76, had developed flesh-eating bacteria that led to an infected ulcer on her big toe. Even the strongest form of an intravenous drug wasn't working, so the next step would have been to cut off the foot.
Otiko stopped the IV drug and started using Diabecline. Within three weeks, everything was cured, he said. "That's never been done before with a topical ointment," he said. "I was amazed." Otiko said most antibiotics kill bacteria with a chemical mechanism. PharmaCline products add a physical form of killing, so the drug is able to physically disrupt the cell wall of the bacteria. That makes it impossible for bacteria to recover.
Source: Sarah Reinecke, Sioux Falls Argus Leader 05/30/2011
http://www.podiatrym.com/pmnewsissues.cfm?pubdate=06/02/2011
NOTE: PHARMACLINE is aka Thru Pharma/Dakota Life Sciences/Kasten (OTC:PK KAST). Steven J. Keough is the named inventor of the delivery system, along with Howard Phillips. Otiko paid Phillips for the right to manufacture Viabecline at Phillips facility in Oklahoma, and to distribute it. These are the 10,000 units Otiko plans to sell in Q2 this year. Viabecline is essentially Diabecline. Keough holds the Trademark to Diabecline and plans to protect their IP.
*****
That script just kind of sat around until I was at a medical convention, and I ran into Christopher Otiko, the executive producer of Axeman.
He said: “You know what, I don’t want to hear anything about medicine. I talk about this stuff all day. Let’s talk about movies. I want to write and produce a horror film, and not a new thing. I want to do something old school.”
I said: “Get outta here, man. I was just setting up a project over here, and I think it’s something you might want to work with me on.”
He saw the script. He liked it, and it was right for his production company, and we sat down and just went through it. What his contribution was, he knew what he wanted for entertainment value to make sure audiences were being entertained every moment throughout the film. What he did was he went through and questioned every single moment.
He said: “Is this really funny? Is this really scary? Is this really dramatic? Is this purposeful to what we’re trying to accomplish? He made it a tighter, more cohesive story. That’s pretty much how we got here. We went into production soon after. While in production, he agreed he wanted to do the entire trilogy. It was just a matter of when. When we finished with distribution, he went ahead and green lit 2 and 3.
The executive producer (Otiko) then brought in an attorney who informed me that he intended to file his own copyright – a fraudulent copyright – to make his agreement with the sales agent valid. I put an end to all the nonsense with a cease and desist letter and the film has just sat. I’ve tried a ridiculous amount of times to bring everyone back to the table and find an amicable solution, but unless it involves me bending over, it just can’t be resolved. And I don’t bend over for nobody. The executive producer lost his money.
Can you link some of the stuff your saying so everyone can see it not just us? So he has a hobby/passion for films hahah but guess what his day job is? He's a doctor not an accountant. Furthermore your assuming his location is like Compton back in the 2000, It is not.
Nope. I can agree to disagree on the perception that all businesses are bad and corrupt. What I see is an integrity issue involving greed and ego. I see a lack of transparency, and forward looking terms about future plans without evidence to support success with those plans.
Otiko was on trial for prescription drug fraud. His wife admitted to the crime, and she testified against him. I don't believe he was clueless. Was he so busy selling diabetic shoes and writing his first novel that he didn't notice his wife was selling prescription drugs using his signature?
He was sanctioned by CA for poor record keeping.
How about the fact he sold a movie on the web while his partner owned movie rights. That has been posted many times. Otiko hasn't refuted this claim. It's still on the web. Otiko worked as Executive Director of the Axeman horror flicks...as recent as 2016. He lost a lot of money on it. There is a parallel here to the delivery system. Take what you think you own and try to make money off it. Otiko told this film owner, at a medical conference, that he didn't care about medicine--he wanted to make horror films.
Where does he perform clinical trials? In that hell hole of an office in Reseda that likely serves Welfare and Medicare recipients? We never see any information about his methods.
Perhaps the time wasn't right? Your assuming that any or all irregularities with Chris or viaderma is a reflection of his product and business. I hate to tell you this if you didn't know all businesses are bad and corrupt, those that make money are perceived as good.
Look at each of his news releases since Otiko, his wife, and brother took this public in 2014. Why do we not see any success stories in follow up news releases or in the financials?
Otiko stated serious going concerns because of debt and an expected Q4 loss. They need money and use news releases to pump the price. The problem is his lack of credibility becomes more and more solidified without evidence of product success.
Are people to believe his clinical data comes from his podiatry clinic in Reseda?
http://www.otcmarkets.com/stock/VDRM/news
It's quite clear nobody believes a thing this guy is putting out. He's just coming out with (ridiculous)new drugs to be used in the cream delivery system. They are so far-fetched that every pop is just a chance for people to bail out or for him to sell more stock. I guess we won't know until something actually hits the market. Right now, this Dr. is coming off as a complete clown. That's the way the market is looking at it.
I know Otiko uses the Phillips/Keough patent-pending delivery system because he states this fact in many places designed for shareholders.
The Annual Report needs to clearly convey his use of this delivery system, the terms, and rights assigned by product name.
He went from an exclusive to non-exclusive license agreement with Phillips in late 2016. This is for Viabecline which is based on the patent-pending delivery system.
The issue is the delivery system that has patent protection. Read all of the filings, and the claims on OTC Profile, and their website.
Otiko is claiming an Award he did not receive.
Very intelligent people excel at fraud. Otiko used a fake copyright document to sell a horror flick online.
If, in his mind, he holds rights to the Phillips/Keough patent-pending invention, he will state this info clearly in the Annual Report. Shareholders can then ask Phillips/Keough to confirm.
Maybe the Journal was informed that Viabecline is a clone of the 2012 Edison Award Winner Diabecline, and pulled their offer?
Otiko knows diabetes. His OK State Thesis was centered on it.
The question I would like answered is why this doctor continues to pump future products that are based on a patent-pending transdermal delivery system he does not hold rights on. He was given rights to manufacture and distribute Viabecline, which is based on this system. Did Phillips give Otiko rights to use the system for other products?
The answer needs to be in the Annual Report.
Moreno is where Otiko worked during his Federal trial for prescription drug fraud.
Googling the address shows that clinic is closed.
No enlightenment needed. I read the original question, gave my opinion that an audit will never happen. I think it's obvious the SEC forms mentioned require an audit.
End of discussion.
I said I'm waiting for a 10q/10k or 8k why will these things never happen neptune?
The "never" response was related to an audit. Otiko chose to not audit his Pink Sheet business.
OTC Pink - an open marketplace for a broad spectrum of equity securities, with no financial standards or reporting requirements. Where is never?
Never means never with no room for probability. This is the DPM that was sanctioned for keeping bad records.
That didn't answer my question.
An audit would reveal where the money has gone, and revenues per product. He would have to reverse himself all on of these claims he has a patent-pending delivery system.
Is that a probability or a likely outcome?
That will never happen. This is an unaudited Pink Sheet family business that rides the coattails of a patent-pending delivery system they do not own.
I'm waiting for 10k/10q or 8k the market decides what is valuable.
Nope. Need the Annual Report and it must be accurate with full disclosures.
Buy! Buy! Buy!
Otiko has to buy the right to use the Phillips/Keough trans-dermal delivery system referenced in my Stickie/iBox. At this time, he only has shown a non-exclusive license to manufacture and distribute the Diabecline clone Viabecline. Phillips has confirmed this agreement.
When the business is centered around a trans-dermal delivery system there are numerous avenues for growth.
Interesting and understandable. Otiko told his horror movie partner he didn't care about medicine, that he wanted to make horror movies. This convo happened at a medical convention!
So they made a movie or two together, then had a falling out. Seems Otiko and his peeps created a false copyright doc so he could sell the Axeman II - A Night to Dismember flick online. This is covered in Item 3. in the link below. Otiko was the Executive Producer. According to Theney, Otiko lost much money on the film. He worked on it in 2016.
http://wickedchannel.com/2017/02/wicked-channel-interview-joston-el-rey-theney-axeman-and-adam-k-2
Quick background:
I sold my entire position a couple weeks ago. Being on the sidelines and looking in from the outside has given me a whole different perspective on these types of things. Before when I was a shareholder I would probably just brush it off and turn a blind eye. But now that I'm looking through a different set of eyes, it really opens them to the potential shadyness of this company.
Someone said as long as they continue forward with similar products using the transdermal system that it doesn't bother them, but for me this raises a red flag.
Here's an analogy: In my mind this is like a car salesman quitting and going to real estate. Sure the sales background aspect is still there, but what does he know about real estate?
I agree. This isn't the first time the word "shady" appeared here. Otiko is a foot and ankle doctor and does understand diabetes.
He has not explained why he references the transdermal delivery system as his own invention--as if he has Carte Blanche to use it as he sees fit (mentioned in iBox and my stickie).
Yes, he does need to sell shares to keep this moving. One might think his next news would be Viabecline units sold to date with all the hoopla surrounding his poster presentation.
Premature ejaculation cream???!!! Others may not agree, but this just seems shady to me. This company is supposed to be focused on Diabetes and now they're taking on this? Something fishy about this. Seems like a ploy to pump the price so the Dr. can sell more shares.
Nope. I need to see the Annual Report and determine whether Otiko plans to continue to infringe on a patent-pending application he has no right to claim as his invention.
In the meantime, my money is getting greener without the help of Otiko's fluff news.
Get in while the pps is low. We will surpass 7 cents by tomorrow.
The last filing indicates 2,799,505,018 Outstanding shares of Common Stock. The Schedule 13G was uploaded to SEC February 16, 2017.
https://www.sec.gov/Archives/edgar/data/1522165/000149315217002131/sc13g.htm
I found it insulting to all shareholders. I left my mod role, sold my position, and will not be back.
I entered when the last published number for Outstanding shares and the Float was well under 500M. I took a loss and moved my money into stocks I can believe in, with management I can trust.
Yes sir it was...why what's your take?
Was this really posted on the Alkame Water Facebook page?
Everyone I share my oil with is surprised at how well it works for pain, relaxation, and more restorative sleep.
Thank you Neptune. I knew their pain products will generate huge revenue on 2018. So I hold my shares for long, hope I can get more money to hold 1.2M shares.
I read it in a filing...don't recall which one.
Is this recent? I was unaware they authorized an increase.